Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
1.
Proc Natl Acad Sci U S A ; 117(24): 13659-13669, 2020 06 16.
Article in English | MEDLINE | ID: mdl-32482872

ABSTRACT

T cell maturation and activation depend upon T cell receptor (TCR) interactions with a wide variety of antigenic peptides displayed in a given major histocompatibility complex (MHC) context. Complementarity-determining region 3 (CDR3) is the most variable part of the TCRα and -ß chains, which govern interactions with peptide-MHC complexes. However, it remains unclear how the CDR3 landscape is shaped by individual MHC context during thymic selection of naïve T cells. We established two mouse strains carrying distinct allelic variants of H2-A and analyzed thymic and peripheral production and TCR repertoires of naïve conventional CD4+ T (Tconv) and naïve regulatory CD4+ T (Treg) cells. Compared with tuberculosis-resistant C57BL/6 (H2-Ab) mice, the tuberculosis-susceptible H2-Aj mice had fewer CD4+ T cells of both subsets in the thymus. In the periphery, this deficiency was only apparent for Tconv and was compensated for by peripheral reconstitution for Treg We show that H2-Aj favors selection of a narrower and more convergent repertoire with more hydrophobic and strongly interacting amino acid residues in the middle of CDR3α and CDR3ß, suggesting more stringent selection against a narrower peptide-MHC-II context. H2-Aj and H2-Ab mice have prominent reciprocal differences in CDR3α and CDR3ß features, probably reflecting distinct modes of TCR fitting to MHC-II variants. These data reveal the mechanics and extent of how MHC-II shapes the naïve CD4+ T cell CDR3 landscape, which essentially defines adaptive response to infections and self-antigens.


Subject(s)
Complementarity Determining Regions/immunology , Histocompatibility Antigens Class II/immunology , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes, Regulatory/immunology , Tuberculosis/genetics , Alleles , Animals , CD4-Positive T-Lymphocytes/immunology , Complementarity Determining Regions/chemistry , Complementarity Determining Regions/genetics , Histocompatibility Antigens Class II/genetics , Humans , Mice , Mice, Inbred C57BL , Receptors, Antigen, T-Cell/chemistry , Receptors, Antigen, T-Cell/genetics , Spleen/immunology , T-Lymphocytes, Regulatory/chemistry , Tuberculosis/immunology
2.
Angew Chem Int Ed Engl ; 60(34): 18694-18703, 2021 08 16.
Article in English | MEDLINE | ID: mdl-34009717

ABSTRACT

We report a novel family of natural lipoglycopeptides produced by Streptomyces sp. INA-Ac-5812. Two major components of the mixture, named gausemycins A and B, were isolated, and their structures were elucidated. The compounds are cyclic peptides with a unique peptide core and several remarkable structural features, including unusual positions of d-amino acids, lack of the Ca2+ -binding Asp-X-Asp-Gly (DXDG) motif, tyrosine glycosylation with arabinose, presence of 2-amino-4-hydroxy-4-phenylbutyric acid (Ahpb) and chlorinated kynurenine (ClKyn), and N-acylation of the ornithine side chain. Gausemycins have pronounced activity against Gram-positive bacteria. Mechanistic studies highlight significant differences compared to known glyco- and lipopeptides. Gausemycins exhibit only slight Ca2+ -dependence of activity and induce no pore formation at low concentrations. Moreover, there is no detectable accumulation of cell wall biosynthesis precursors under treatment with gausemycins.


Subject(s)
Lipoglycopeptides/isolation & purification , Streptomyces/chemistry , Lipoglycopeptides/chemistry , Molecular Conformation
3.
Antimicrob Agents Chemother ; 60(10): 6422-4, 2016 10.
Article in English | MEDLINE | ID: mdl-27503657

ABSTRACT

Among 230 target-synthesized indole-based compounds, seven 3-triazenoindoles showed MICs of 0.2 to 0.5 µg/ml against Mycobacterium tuberculosis strain H37Rv and isoniazid-resistant human isolate CN-40. The TU112 compound was active also against a dormant form of M. tuberculosis Some of these triazenoindoles were active against Mycobacterium avium, with MICs of 0.05 to 0.5 µg/ml. The selectivity indices (SI) for M. tuberculosis and M. avium were significantly higher than 10, making these compounds acceptable for the next testing step.


Subject(s)
Antitubercular Agents/pharmacology , Mycobacterium avium/drug effects , Mycobacterium tuberculosis/drug effects , Antitubercular Agents/chemistry , Drug Evaluation, Preclinical/methods , Drug Resistance, Bacterial/drug effects , Humans , Indoles/chemistry , Indoles/pharmacology , Isoniazid/pharmacology , Microbial Sensitivity Tests , Mycobacterium tuberculosis/isolation & purification
4.
Front Immunol ; 15: 1380971, 2024.
Article in English | MEDLINE | ID: mdl-38799462

ABSTRACT

Mycobacterium tuberculosis (Mtb) remains a major threat worldwide, although only a fraction of infected individuals develops tuberculosis (TB). TB susceptibility is shaped by multiple genetic factors, and we performed comparative immunological analysis of two mouse strains to uncover relevant mechanisms underlying susceptibility and resistance. C57BL/6 mice are relatively TB-resistant, whereas I/St mice are prone to develop severe TB, partly due to the MHC-II allelic variant that shapes suboptimal CD4+ T cell receptor repertoire. We investigated the repertoires of lung-infiltrating helper T cells and B cells at the progressed stage in both strains. We found that lung CD4+ T cell repertoires of infected C57BL/6 but not I/St mice contained convergent TCR clusters with functionally confirmed Mtb specificity. Transcriptomic analysis revealed a more prominent Th1 signature in C57BL/6, and expression of pro-inflammatory IL-16 in I/St lung-infiltrating helper T cells. The two strains also showed distinct Th2 signatures. Furthermore, the humoral response of I/St mice was delayed, less focused, and dominated by IgG/IgM isotypes, whereas C57BL/6 mice generated more Mtb antigen-focused IgA response. We conclude that the inability of I/St mice to produce a timely and efficient anti-Mtb adaptive immune responses arises from a suboptimal helper T cell landscape that also impacts the humoral response, leading to diffuse inflammation and severe disease.


Subject(s)
Adaptive Immunity , Genetic Predisposition to Disease , Mice, Inbred C57BL , Mycobacterium tuberculosis , Tuberculosis , Animals , Mice , Mycobacterium tuberculosis/immunology , Adaptive Immunity/genetics , Tuberculosis/immunology , Tuberculosis/genetics , Lung/immunology , Lung/pathology , B-Lymphocytes/immunology , Disease Models, Animal , Receptors, Antigen, T-Cell/genetics , Receptors, Antigen, T-Cell/immunology
5.
Sci Rep ; 14(1): 846, 2024 01 08.
Article in English | MEDLINE | ID: mdl-38191600

ABSTRACT

Mycobacterium tuberculosis (Mtb) is able to transition into a dormant state, causing the latent state of tuberculosis. Dormant mycobacteria acquire resistance to all known antibacterial drugs and can survive in the human body for decades before becoming active. In the dormant forms of M. tuberculosis, the synthesis of porphyrins and its Zn-complexes significantly increased when 5-aminolevulinic acid (ALA) was added to the growth medium. Transcriptome analysis revealed an activation of 8 genes involved in the metabolism of tetrapyrroles during the Mtb transition into a dormant state, which may lead to the observed accumulation of free porphyrins. Dormant Mtb viability was reduced by more than 99.99% under illumination for 30 min (300 J/cm2) with 565 nm light that correspond for Zn-porphyrin and coproporphyrin absorptions. We did not observe any PDI effect in vitro using active bacteria grown without ALA. However, after accumulation of active cells in lung macrophages and their persistence within macrophages for several days in the presence of ALA, a significant sensitivity of active Mtb cells (ca. 99.99%) to light exposure was developed. These findings create a perspective for the treatment of latent and multidrug-resistant tuberculosis by the eradication of the pathogen in order to prevent recurrence of this disease.


Subject(s)
Mycobacterium tuberculosis , Porphyrins , Tuberculosis , Humans , Aminolevulinic Acid/pharmacology , Macrophages , Zinc
6.
Pharmaceuticals (Basel) ; 16(5)2023 May 02.
Article in English | MEDLINE | ID: mdl-37242470

ABSTRACT

The penetration of substances through the bacterial cell envelope is a complex and underinvestigated process. Mitochondria-targeted antioxidant and antibiotic SkQ1 (10-(plastoquinonyl)decyltriphenylphosphonium) is an excellent model for studying the penetration of substances through the bacterial cell envelope. SkQ1 resistance in Gram-negative bacteria has been found to be dependent on the presence of the AcrAB-TolC pump, while Gram-positive bacteria do not have this pump but, instead, have a mycolic acid-containing cell wall that is a tough barrier against many antibiotics. Here, we report the bactericidal action of SkQ1 and dodecyl triphenylphospho-nium (C12TPP) against Rhodococcus fascians and Mycobacterium tuberculosis, pathogens of plants and humans. The mechanism of the bactericidal action is based on the penetration of SkQ1 and C12TPP through the cell envelope and the disruption of the bioenergetics of bacteria. One, but probably not the only such mechanism is a decrease in membrane potential, which is important for the implementation of many cellular processes. Thus, neither the presence of MDR pumps, nor the presence of porins, prevents the penetration of SkQ1 and C12TPP through the complex cell envelope of R. fascians and M. tuberculosis.

7.
J Immunol ; 184(3): 1227-34, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-20028653

ABSTRACT

Mutations in the btk gene encoding Bruton's tyrosine kinase cause X-linked immune deficiency, with impaired B lymphocyte function as the major phenotype. Earlier, we demonstrated that CBA/N-xid mice, unlike the wild-type CBA mice, were not protected by bacillus Calmette-Guérin (BCG) vaccination against tuberculosis infection. Because IFN-gamma-producing T cells and activated macrophages are key elements of antituberculosis protection, it remained unclear how the mutation predominantly affecting B cell functions interferes with responses along the T cell-macrophage axis. In this study, we show that B cell deficiency leads to an abnormally rapid neutrophil migration toward the site of external stimulus. Using adoptive cell transfers and B cell genetic knockout, we demonstrate a previously unappreciated capacity of B cells to downregulate neutrophil motility. In our system, an advanced capture of BCG by neutrophils instead of macrophages leads to a significant decrease in numbers of IFN-gamma-producing T cells and impairs BCG performance in X-linked immune-deficient mice. The defect is readily compensated for by the in vivo neutrophil depletion.


Subject(s)
B-Lymphocyte Subsets/cytology , B-Lymphocyte Subsets/immunology , BCG Vaccine/administration & dosage , BCG Vaccine/immunology , Cell Migration Inhibition/immunology , Tuberculosis, Pulmonary/prevention & control , Adoptive Transfer , Animals , B-Lymphocyte Subsets/transplantation , Cell Line , Chemotaxis, Leukocyte/genetics , Chemotaxis, Leukocyte/immunology , Female , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Knockout , Time Factors , Tuberculosis, Pulmonary/pathology
8.
Immunology ; 134(2): 109-15, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21896006

ABSTRACT

Relevance and accuracy of experimental mouse models of tuberculosis (TB) are the subject of constant debate. This article briefly reviews genetic aspects of this problem and provides a few examples of mycobacterial diseases with similar or identical genetic control in mice and humans. The two species display more similarities than differences regarding both genetics of susceptibility/severity of mycobacterial diseases and the networks of protective and pathological immune reactions. In the opinion of the author, refined mouse models of mycobacterial diseases are extremely useful for modelling the corresponding human conditions, if genetic diversity is taken into account.


Subject(s)
Disease Models, Animal , Tuberculosis/genetics , Animals , Cation Transport Proteins/genetics , Gene Knockout Techniques , Genetic Predisposition to Disease , Genetic Variation , Humans , Immune System Diseases/genetics , Interferon Regulatory Factors/genetics , Mice , Minor Histocompatibility Antigens , Multifactorial Inheritance , Nuclear Proteins/genetics , Severity of Illness Index , Trans-Activators/genetics , Tuberculosis/immunology
9.
Antibiotics (Basel) ; 9(6)2020 Jun 24.
Article in English | MEDLINE | ID: mdl-32599854

ABSTRACT

We synthesized 100 novel indole-based compounds with polyaza-functionalities, including 3-triazeneindoles, and tested their activity in vitro against laboratory M. tuberculosis H37Rv and clinical izoniazid-resistant CN-40 isolates, using gross and fine titration approaches. Here we present a few 3-triazeneindoles with the highest anti-mycobacterial activity. Introduction of short lipid tails into the 3-triazeneindole core additionally increased their activity against mycobacteria engulfed by murine macrophages. We also demonstrate that the compound TU112, one of the most active in our previous study, being not bioavailable after administration in mice per os, manifests prominent anti-mycobacterial activity after intravenous or aerosol delivery, as assessed by the mouse serum and lung supernatant titration assays.

10.
Tuberculosis (Edinb) ; 114: 1-8, 2019 01.
Article in English | MEDLINE | ID: mdl-30711147

ABSTRACT

The role of B cells and antibodies in tuberculosis (TB) immunity, protection and pathogenesis remain contradictory. The presence of organized B cell follicles close to active TB lesions in the lung tissue raises the question about the role of these cells in local host-pathogen interactions. In this short review, we summarize the state of our knowledge concerning phenotypes of B cells populating tuberculous lungs, their secretory activity, interactions with other immune cells and possible involvement in protective vs. pathogenic TB immunity.


Subject(s)
B-Lymphocyte Subsets/immunology , Tuberculosis, Pulmonary/immunology , Animals , Antibodies, Bacterial/biosynthesis , Cytokines/immunology , Host-Pathogen Interactions , Humans , Immunity, Cellular , Immunization, Passive/methods , Immunophenotyping , Mycobacterium tuberculosis/immunology , Tuberculosis, Pulmonary/prevention & control
12.
Tuberculosis (Edinb) ; 113: 130-138, 2018 12.
Article in English | MEDLINE | ID: mdl-30514495

ABSTRACT

TB infection in mice develops relatively rapidly which interferes with experimental dissection of immune responses and lung pathology features that differ between genetically susceptible and resistant hosts. Earlier we have shown that the M. tuberculosis strain lacking four of five Rpf genes (ΔACDE) is seriously attenuated for growth in vivo. Using this strain, we assessed key parameters of lung pathology, immune and inflammatory responses in chronic and reactivation TB infections in highly susceptible I/St and more resistant B6 mice. ΔACDE mycobacteria progressively multiplied only in I/St lungs, whilst in B6 lung CFU counts decreased with time. Condensed TB foci apeared in B6 lungs at week 4 of infection, whilst in I/St their formation was delayed. At the late phase of infection, in I/St lungs TB foci fused resulting in extensive pneumonia, whereas in B6 lungs pathology was limited to condensed foci. Macrophage and neutrophil populations characteristically differed between I/St and B6 mice at early and late stages of infection: more neutrophils accumulated in I/St and more macrophages in B6 lungs. The expression level of chemokine genes involved in neutrophil influx was higher in I/St compared to B6 lungs. B6 lung cells produced more IFN-γ, IL-6 and IL-11 at the early and late phases of infection. Overall, using a new mouse model of slow TB progression, we demonstrate two important features of ineffective infection control underlined by shifts in lung inflammation: delay in early granuloma formation and fusion of granulomas resulting in consolidated pneumonia late in the infectious course.


Subject(s)
Lung/microbiology , Mycobacterium tuberculosis/genetics , Tuberculosis, Pulmonary/microbiology , Animals , Bacterial Load , Chronic Disease , Cytokines/metabolism , Disease Models, Animal , Disease Progression , Female , Genotype , Granuloma, Respiratory Tract/immunology , Granuloma, Respiratory Tract/metabolism , Granuloma, Respiratory Tract/microbiology , Host-Pathogen Interactions , Inflammation Mediators/metabolism , Lung/immunology , Lung/pathology , Macrophages/immunology , Macrophages/metabolism , Macrophages/microbiology , Mice, Inbred C57BL , Microbial Viability , Mutation , Mycobacterium tuberculosis/pathogenicity , Neutrophils/immunology , Neutrophils/metabolism , Neutrophils/microbiology , Phenotype , Pneumonia/immunology , Pneumonia/metabolism , Pneumonia/microbiology , Time Factors , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/pathology
13.
J Leukoc Biol ; 79(4): 739-46, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16415170

ABSTRACT

Genetic variation in the major histocompatibility complex (MHC) influences susceptibility and immune responses to Mycobacterium tuberculosis in mice and humans, but connections among the severity of tuberculosis (TB), dynamic changes in T cell responses to mycobacteria, and MHC genetic polymorphisms are poorly characterized. The overall effect of the MHC genes on TB susceptibility and cellular responses to mycobacteria is moderate; thus, such studies provide reliable results only if congenic mouse strains bearing a variety of H2 haplotypes on an identical genetic background are analyzed. Using a panel of H2-congenic strains on the B10 background, we demonstrate that T cells from mice of three different strains, which are resistant to TB infection, readily respond by proliferation to repeated stimulations with mycobacterial sonicate, whereas T cells from three susceptible mouse strains die after the second stimulation with antigen. This difference is specific, as T cells from TB-susceptible and -resistant mouse strains do not differ in response to irrelevant antigens. The CD4/CD8 ratio in immune lymph nodes correlates strongly and inversely with TB susceptibility, being significantly lower in resistant mice as a result of an increased content of CD8+ cells. These differences between the two sets of mouse strains correlate with an elevated level of activation-induced T cell apoptosis in TB-susceptible mice and a higher proportion of activated CD44+ CD62 ligand- T cells in TB-resistant mice. These results may shed some light on the nature of the cellular basis of MHC-linked differences in susceptibility to TB.


Subject(s)
Antigens, Bacterial/immunology , Apoptosis/immunology , H-2 Antigens/immunology , Immunity, Innate/immunology , T-Lymphocytes/immunology , Tuberculosis, Pulmonary/immunology , Animals , Animals, Congenic/immunology , CD4-CD8 Ratio , Disease Models, Animal , Female , Haplotypes , Major Histocompatibility Complex/genetics , Major Histocompatibility Complex/immunology , Mice , Mice, Inbred C57BL , Mycobacterium tuberculosis/immunology
14.
Article in English | MEDLINE | ID: mdl-28861399

ABSTRACT

Earlier we demonstrated that the adenylyl cyclase (AC) encoded by the MSMEG_4279 gene plays a key role in the resuscitation and growth of dormant Mycobacterium smegmatis and that overexpression of this gene leads to an increase in intracellular cAMP concentration and prevents the transition of M. smegmatis from active growth to dormancy in an extended stationary phase accompanied by medium acidification. We surmised that the homologous Rv2212 gene of M. tuberculosis (Mtb), the main cAMP producer, plays similar physiological roles by supporting, under these conditions, the active state and reactivation of dormant bacteria. To test this hypothesis, we established Mtb strain overexpressing Rv2212 and compared its in vitro and in vivo growth characteristics with a control strain. In vitro, the AC-overexpressing pMindRv2212 strain demonstrated faster growth in a liquid medium, prolonged capacity to form CFUs and a significant delay or even prevention of transition toward dormancy. AC-overexpressing cells exhibited easier recovery from dormancy. In vivo, AC-overexpressing bacteria demonstrated significantly higher growth rates (virulence) in the lungs and spleens of infected mice compared to the control strain, and, unlike the latter, killed mice in the TB-resistant strain before month 8 of infection. Even in the absence of selecting hygromycin B, all pMindRv2212 CFUs retained the Rv2212 insert during in vivo growth, strongly suggesting that AC overexpression is beneficial for bacteria. Taken together, our results indicate that cAMP supports the maintenance of Mtb cells vitality under unfavorable conditions in vitro and their virulence in vivo.


Subject(s)
Adenylyl Cyclases/genetics , Adenylyl Cyclases/metabolism , Gene Expression Regulation, Bacterial , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/metabolism , Tuberculosis/microbiology , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Colony Count, Microbial , Cyclic AMP/metabolism , Disease Models, Animal , Female , Hygromycin B/pharmacology , Lung/microbiology , Lung/pathology , Mice , Mice, Inbred C57BL , Mycobacterium tuberculosis/growth & development , Mycobacterium tuberculosis/pathogenicity , Spleen/microbiology , Spleen/physiology , Tuberculosis/pathology , Virulence
16.
Tuberculosis (Edinb) ; 93(3): 285-90, 2013 May.
Article in English | MEDLINE | ID: mdl-23491715

ABSTRACT

Mice as a species are susceptible to tuberculosis infection while mouse inbred strains present wide spectrum of susceptibility/resistance to this infection. However, non-tuberculosis Mycobacterial infections usually cannot be modeled in mice of common inbred strains. Introduction of specific properties, such as gene mutations, recombinants, targeted gene knockouts significantly extended the use of mice to mimic human Mycobacterial infections, including non-tuberculosis ones. This review describes the available mouse models of tuberculosis and non-tuberculosis infections and drug therapy in these models. Mouse models of non-tuberculosis infections are significantly less developed than tuberculosis models, hampering the development of therapies.


Subject(s)
Antitubercular Agents/therapeutic use , Disease Models, Animal , Mycobacterium Infections, Nontuberculous/drug therapy , Tuberculosis/drug therapy , Animals , Genetic Predisposition to Disease , Mice , Mice, Inbred Strains , Microbial Sensitivity Tests/methods , Mycobacterium Infections, Nontuberculous/genetics , Tuberculosis/genetics
17.
PLoS One ; 8(8): e72773, 2013.
Article in English | MEDLINE | ID: mdl-23977351

ABSTRACT

The balance between activation and inhibition of local immune responses in affected tissues during prolonged chronic infections is important for host protection. There is ample evidence that regulatory, tolerogenic dendritic cells (DC) are developed and present in tissues and inhibit overwhelming inflammatory reactions. Also, it was firmly established that stromal microenvironment of many organs is able to induce development of immature regulatory DC (DCreg), an essential element of a general immune regulatory network. However, direct experimental data demonstrating inhibition of immune responses by stroma-instructed immature DCreg in infectious models are scarce, and virtually nothing is known about functioning of this axis of immunity during tuberculosis (TB) infection. In this study, we demonstrate that lung stromal cells are capable of supporting the development in culture of immature CD11b(+)CD11c(low)CD103(-) DCreg from lineage-negative (lin(-)) bone marrow precursors. DCreg developed on lung stroma isolated from mice of genetically TB-hyper-susceptible I/St and relatively resistant B6 inbred strains inhibited proliferative response of mycobacteria-specific CD4(+) T-cell lines a dose-dependent manner. Importantly, the inhibitory activity of B6 DCreg was substantially higher than that of I/St Dcreg. Moreover, when the donors of stromal cells were chronically infected with virulent mycobacteria, the capacity to instruct inhibitory DCreg was retained in B6, but further diminished in I/St stromal cells. DCreg-provided suppression was mediated by a few soluble mediators, including PGE2, NO and IL-10. The content of CD4(+)Foxp3(+) Treg cells in the mediastinal, lung-draining lymph nodes at the advanced stages of chronic infection did not change in I/St, but increased 2-fold in B6 mice, and lung pathology was much more pronounced in the former mice. Taken together, these data provide genetic evidence that the capacity to maintain populations of regulatory cells during M. tuberculosis infection is a part of the host protective strategy.


Subject(s)
Dendritic Cells/immunology , Genetic Predisposition to Disease , Lung/pathology , Mycobacterium tuberculosis/physiology , Tuberculosis/immunology , Tuberculosis/microbiology , Aerosols , Animals , Antigens, Bacterial/immunology , Cell Adhesion , Coculture Techniques , Lymph Nodes/immunology , Lymph Nodes/pathology , Lymphocyte Count , Mice, Inbred C57BL , Phenotype , Solubility , Stromal Cells/pathology , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/microbiology , Tuberculosis/genetics
18.
PLoS One ; 6(7): e21878, 2011.
Article in English | MEDLINE | ID: mdl-21789190

ABSTRACT

IL-11 is multifunctional cytokine whose physiological role in the lungs during pulmonary tuberculosis (TB) is poorly understood. Here, using in vivo administration of specific antibodies against IL-11, we demonstrate for the first time that blocking IL-11 diminishes histopathology and neutrophilic infiltration of the lung tissue in TB-infected genetically susceptible mice. Antibody treatment decreased the pulmonary levels of IL-11 and other key inflammatory cytokines not belonging to the Th1 axis, and down-regulated IL-11 mRNA expression. This suggests the existence of a positive feedback loop at the transcriptional level, which is further supported by up-regulation of IL-11 mRNA expression in the presence of rIL-11 in in vitro cultures of lung cells. These findings imply a pathogenic role for IL-11 during the early phase of Mycobacterium tuberculosis-triggered disease in a genetically susceptible host.


Subject(s)
Genetic Predisposition to Disease , Interleukin-11/immunology , Mycobacterium tuberculosis/immunology , Pneumonia/immunology , Pneumonia/microbiology , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/microbiology , Animals , Antibodies/administration & dosage , Antibodies/therapeutic use , Autocrine Communication , Female , Interleukin-11/biosynthesis , Interleukin-11/genetics , Lung/immunology , Lung/microbiology , Lung/pathology , Mice , Pneumonia/complications , Pneumonia/drug therapy , Transcription, Genetic , Tuberculosis, Pulmonary/complications , Tuberculosis, Pulmonary/drug therapy
19.
J Immunol ; 178(2): 976-85, 2007 Jan 15.
Article in English | MEDLINE | ID: mdl-17202360

ABSTRACT

The generation of effector, IFN-gamma producing T lymphocytes and their accumulation at sites of infection are critical for host protection against various infectious diseases. The activation and differentiation of naive T lymphocytes into effector memory cells starts in lymphoid tissues, but it is not clear whether the Ag-experienced cells that leave lymph nodes (LN) are mature or if they undergo further changes in the periphery. We have previously shown that CD44(high)CD62L(low) effector CD4 T lymphocytes generated during the course of mycobacterial infection can be segregated into two subsets on the basis of CD27 receptor expression. Only the CD27(low) subset exhibited a high capacity for IFN-gamma secretion, indicating that low CD27 expression is characteristic of fully differentiated effector CD4 T lymphocytes. We demonstrate now that CD27(low) IFN-gamma-producing CD4 T lymphocytes accumulate in the lungs but are rare in LNs. Several factors contribute to their preferential accumulation. First, CD27(low) CD4 T lymphocytes present in the LN are highly susceptible to apoptosis. Second, circulating CD27(low) CD4 T cells do not enter the LN but efficiently migrate to the lungs. Third, CD27(high) effector CD4 T cells that enter the lungs down-regulate CD27 expression in situ. In genetically heterogeneous mice that exhibit varying susceptibility to tuberculosis, the accumulation of mature CD27(low) CD4 T cells in the lungs correlates with the degree of protection against infection. Thus, we propose that terminal maturation of effector CD4 T lymphocytes in the periphery provides the host with efficient local defense and avoids potentially harmful actions of inflammatory cytokines in lymphoid organs.


Subject(s)
CD4-Positive T-Lymphocytes/metabolism , Interferon-gamma/biosynthesis , Mycobacterium bovis/physiology , Mycobacterium tuberculosis/physiology , Tuberculosis/metabolism , Tuberculosis/prevention & control , Tumor Necrosis Factor Receptor Superfamily, Member 7/metabolism , Animals , Apoptosis , CD4-Positive T-Lymphocytes/cytology , Cell Movement , Down-Regulation , Female , Lymphoid Tissue/cytology , Lymphoid Tissue/metabolism , Mice , Mice, Inbred C57BL , Tuberculosis/microbiology
20.
Infect Immun ; 74(6): 3668-72, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16714600

ABSTRACT

Interstitial lung macrophages from tuberculosis-susceptible I/St and tuberculosis-resistant A/Sn mice demonstrated significant constitutive differences in gene expression levels, whereas in vitro infection of these cells with Mycobacterium tuberculosis had only a modulatory impact on gene expression. We conclude that intrinsic gene expression profiles are an important determinant of tuberculosis pathogenesis in mice.


Subject(s)
Gene Expression Profiling , Genetic Predisposition to Disease , Macrophages/metabolism , Tuberculosis/genetics , Animals , Chemokines/genetics , Cytokines/genetics , Macrophages/microbiology , Mice , Oligonucleotide Array Sequence Analysis
SELECTION OF CITATIONS
SEARCH DETAIL